We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$14.6B
AUM Growth
+$1.56B
Cap. Flow
+$821M
Cap. Flow %
5.61%
Top 10 Hldgs %
12.87%
Holding
2,224
New
106
Increased
1,383
Reduced
640
Closed
82

Top Buys

Rank Stock Value
1
CUK
Carnival PLC
CUK
+$33.6M
2
BAX icon
Baxter International
BAX
+$28.7M
3
AAPL icon
Apple
AAPL
+$20.5M
4
MO icon
Altria Group
MO
+$18.9M
5
T icon
AT&T
T
+$18.1M

Sector Composition

Rank Sector Weight
1 Financials 17.66%
2 Technology 15.49%
3 Healthcare 12.76%
4 Industrials 9.47%
5 Consumer Discretionary 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDRX
2026
DELISTED
Veradigm Inc. Common Stock
MDRX
$205K ﹤0.01%
16,156
+5,014
+45% +$59.5K
HMY icon
2027
Harmony Gold Mining
HMY
$9.7B
$204K ﹤0.01%
83,345
+50,558
+154% +$126K
OCSL icon
2028
Oaktree Specialty Lending
OCSL
$1.05B
$204K ﹤0.01%
+14,740
New +$220K
RYAM icon
2029
Rayonier Advanced Materials
RYAM
$562M
$204K ﹤0.01%
15,153
-230
-1% -$3.23K
LORL
2030
DELISTED
Loral Space and Communications, Inc.
LORL
$204K ﹤0.01%
5,170
-173
-3% -$6.92K
LDL
2031
DELISTED
Lydall, Inc.
LDL
$204K ﹤0.01%
3,807
+87
+2% +$4.94K
ASND icon
2032
Ascendis Pharma A/S
ASND
$16.5B
$203K ﹤0.01%
+7,242
New +$183K
OCLR
2033
DELISTED
Oclaro Inc.
OCLR
$203K ﹤0.01%
20,710
-1,340
-6% -$12.6K
CNMD icon
2034
CONMED
CNMD
$1.3B
$202K ﹤0.01%
4,547
-2,462
-35% -$106K
ZWS icon
2035
Zurn Elkay Water Solutions
ZWS
$8.55B
$202K ﹤0.01%
+18,126
New +$195K
IBTX
2036
DELISTED
Independent Bank Group, Inc.
IBTX
$202K ﹤0.01%
+3,147
New +$198K
IRWD icon
2037
Ironwood Pharmaceuticals
IRWD
$586M
$201K ﹤0.01%
14,093
+1,531
+12% +$20.9K
NMBL
2038
DELISTED
Nimble Storage, Inc.
NMBL
$201K ﹤0.01%
16,068
+2,983
+23% +$29.2K
DATA
2039
DELISTED
Tableau Software, Inc.
DATA
$200K ﹤0.01%
+4,043
New +$200K
EVER
2040
DELISTED
Everbank Financial Corp
EVER
$198K ﹤0.01%
+10,179
New +$198K
CDR
2041
DELISTED
Cedar Realty Trust, Inc
CDR
$196K ﹤0.01%
5,902
-2,021
-26% -$77.5K
SNR
2042
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$194K ﹤0.01%
18,971
+1,892
+11% +$19.2K
AMPH icon
2043
Amphastar Pharmaceuticals
AMPH
$907M
$193K ﹤0.01%
+13,324
New +$210K
BKE icon
2044
Buckle
BKE
$2.32B
$193K ﹤0.01%
10,373
+812
+8% +$16.4K
KE
2045
Kimball Electronics
KE
$564M
$193K ﹤0.01%
11,396
+822
+8% +$13.7K
PBPB
2046
DELISTED
Potbelly
PBPB
$191K ﹤0.01%
13,724
+1,702
+14% +$22.4K
SXC icon
2047
SunCoke Energy
SXC
$794M
$191K ﹤0.01%
21,264
-4,947
-19% -$48.4K
FRAN
2048
DELISTED
Francesca's Holdings Corporation
FRAN
$191K ﹤0.01%
1,034
+3
+0.3% +$621
BKCC
2049
DELISTED
BlackRock Capital Investment Corporation
BKCC
$190K ﹤0.01%
25,193
-16,556
-40% -$124K
MBI icon
2050
MBIA
MBI
$275M
$189K ﹤0.01%
22,367
-230
-1% -$2.31K

Similar funds

Aperio Group's Q1 2017 Portfolio in Review

As of Q1 2017, Aperio Group held 2,224 positions worth $14.6B, up 12% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Aperio Group deployed $821M of net new capital in Q1 2017, opening 106 new positions and adding to 1,383 existing holdings. Its largest new stake was Qiagen: 190,817 shares worth $5.86M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was ExxonMobil, an estimated $23.2M trimmed.

  • Aperio Group's largest Q1 2017 buy was Qiagen: 190,817 shares worth $5.86M.
  • Aperio Group added most to Carnival PLC in Q1 2017, an estimated $33.6M increase.
  • Aperio Group's biggest Q1 2017 reduction was ExxonMobil, cutting an estimated $23.2M.
  • Aperio Group fully exited Endurance Specialty Holdings Ltd in Q1 2017, selling an estimated $20.5M.
  • Aperio Group's ten largest holdings make up 13% of its $14.6B portfolio in Q1 2017.
  • Aperio Group opened 106 new positions and closed 82 in Q1 2017.
  • Aperio Group's portfolio value rose 12% quarter-over-quarter to $14.6B.

Based on Aperio Group's 13F filing for Q1 2017, filed 5 May 2017.